사료용 효모 시장 - 예측(2026-2031년)

Feed Yeast Market is projected to expand at a 4.53% CAGR, attaining USD 2.323 billion in 2031 from USD 1.781 billion in 2025.

Feed yeast-predominantly live or inactivated Saccharomyces cerevisiae, along with specialty strains such as Candida utilis (torula) and Kluyveromyces spp.-has become a cornerstone functional additive in modern monogastric and ruminant nutrition. Active dry yeast, yeast culture, hydrolyzed yeast, and selenium-enriched derivatives deliver multiple modes of action: stabilization of rumen pH through oxygen scavenging and preferential stimulation of cellulolytic bacteria in cattle, enhanced fiber digestibility, reduced risk of sub-acute ruminal acidosis (SARA), improved volatile fatty acid profiles, and direct prebiotic effects via mannans and B-glucans that bind enteric pathogens and modulate gut-associated lymphoid tissue.

In poultry and swine, yeast fractions consistently demonstrate 2-5 % improvements in feed conversion ratio, increased villus height:crypt depth ratios, and measurable reductions in Salmonella and E. coli colonization. Hydrolyzed yeast products rich in nucleotides and glutamic acid are increasingly specified in post-weaning piglet diets and early broiler starter phases to accelerate gut maturation and mitigate the growth check previously managed by antibiotic growth promoters now banned in most major markets.

The structural growth drivers remain unchanged: global meat and egg demand continues its upward trajectory, particularly in Asia-Pacific where per-capita poultry consumption is still far below saturation levels; regulatory phase-out of in-feed antibiotics has created a permanent void that yeast-based solutions fill cost-effectively; and the protein transition in aquaculture and pet food is elevating demand for palatable, immune-modulating ingredients that do not carry marine-allergen risk.

Asia-Pacific has solidified its position as both the largest production and consumption region. China, Vietnam, Thailand, and India combine massive poultry and swine integrator capacity with aggressive modernization of dairy and beef feedlots. Local yeast fermentation capacity-often co-located with ethanol, citric acid, or brewery plants-keeps delivered cost competitive against imported specialty additives. North America maintains leadership in innovation and high-specification products (organic selenium yeast, nucleotide-enriched hydrolysates) while benefiting from sophisticated nutritionist networks that readily adopt evidence-based functional feeds.

Poultry remains the dominant species segment by volume and value. Broilers and layers respond predictably to live yeast and yeast culture inclusion at 0.5-2 kg/t, with commercial field trials routinely reporting 3-6 points FCR improvement and 1-2 % livability gains under heat-stress or high-density conditions. Egg producers increasingly specify yeast derivatives for shell quality and yolk color stability in antibiotic-free and cage-free systems.

Commercial portfolios have matured into four distinct categories:

1. Live yeast (>=15 X 109 CFU/g) targeted at rumen modulation and lactating dairy performance.

2. Inactive whole yeast and yeast culture for general gut health across species.

3. Yeast cell-wall fractions (MOS + B-glucans) as direct pathogen binders and immune stimulants.

4. Hydrolyzed yeast and nucleotide products for early-life nutrition and palatability enhancement.

Cost-of-gain calculations typically show payback ratios of 3:1 to 8:1 under commercial conditions, making yeast one of the most economically attractive alternatives in the post-AGP era.

In conclusion, feed yeast has transitioned from niche additive to standard inclusion in high-performance rations across poultry, swine, and dairy. Its multifaceted benefits-rumen stabilization, pathogen control, immune modulation, and nutrient bioavailability-align perfectly with the industry's simultaneous pursuit of productivity, sustainability, and antibiotic-free certification. Companies controlling large-scale, low-cost fermentation assets while maintaining strain-specific efficacy data will continue to dominate a category where technical differentiation still commands meaningful premiums despite increasing commoditization pressure.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Market Segmentation:

• By Type
• Live Yeast
• Spent Yeast
• Yeast Derivatives
• By Form
• Fresh
• Dry
• By Animal
• Swine
• Poultry
• Aqua
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. FEED YEAST MARKET BY TYPE

• 5.1. Introduction
• 5.2. Live Yeast
• 5.3. Spent Yeast
• 5.4. Yeast Derivatives

6. FEED YEAST MARKET BY FORM

• 6.1. Introduction
• 6.2. Fresh
• 6.3. Dry

7. FEED YEAST MARKET BY ANIMAL

• 7.1. Introduction
• 7.2. Swine
• 7.3. Poultry
• 7.4. Aqua
• 7.5. Others

8. FEED YEAST MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. ADM
• 10.2. Nutreco
• 10.3. Ohly
• 10.4. Alltech Inc.
• 10.5. LALLEMAND Inc.
• 10.6. Leiber
• 10.7. AngelYeast Co., Ltd.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations